Business ❯Market Competition

Pharmaceutical Industry

Generic Drugs Obesity Drug Market Eli Lilly vs Novo Nordisk Obesity Drugs Drug Development Weight Loss Drugs Drug Competition Novo Nordisk

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Novo Nordisk's Amycretin Shows Promise as Next-Gen Weight Loss Drug